- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05122598
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
- Navn: Evaristus Nwulia, MD
- Telefonnummer: 410-227-2005
- E-mail: enwulia@evonmedics.org
Undersøgelse Kontakt Backup
- Navn: Maria Hipolito, MD
- Telefonnummer: 571-241-2766
- E-mail: mhipolito@evonmedics.org
Studiesteder
-
-
District of Columbia
-
Washington, District of Columbia, Forenede Stater, 20002
- Rekruttering
- Clinics of Dr. Edwin Chapman @ MHDG
-
Kontakt:
- Edwin Chapman, MD
- Telefonnummer: 202-396-8550
- E-mail: echap1647@aol.com
-
Washington, District of Columbia, Forenede Stater, 20020
- Rekruttering
- Family and Medical Counseling Service, Inc
-
Kontakt:
- Michael Serlin, MD
- Telefonnummer: 573 202-889-7900
- E-mail: mserlin@fmcsinc.org]
-
Washington, District of Columbia, Forenede Stater, 20060
- Rekruttering
- Howard University (HU)
-
Kontakt:
- Thomas O Obisesan, MD
- Telefonnummer: 202-865-6100
- E-mail: tobisesan@howard.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age 55-95 years; female must be post-menopausal for ≥ 2 consecutive years
- Probable mild AD according to the core clinical criteria outlined in the National Institute on Aging/Alzheimer's Association (NIA-AA) Guidelines
- MMSE score between the range of 21 to 27; CDR score of 1.0 (mild AD); scores on Logical Memory II subscale (Delayed Recall) from the Wechsler Memory Scale-Revised (WMS) within the recommended education-adjusted ranges
- Have either cerebrospinal fluid (CSF) Aβ42 levels that are consistent with Alzheimer's disease as measured via mass spectrometry by C2N, or document elevated amyloid burden consistent with Alzheimer's disease from positron emission tomography (PET) imaging
- Screening MRI without evidence of infection, infarction, or other focal lesions of neurological disease; and no significant nasal disease.
- All participants must have a study partner with normal cognitive function.
Exclusion Criteria:
- Any significant neurologic disease
- Major psychiatric disorder within the past 2 years
- Substance use disorder within the past 2 years
- Any unstable medical condition
- Contraindications to MRI
- Any Alzheimer's disease modifying therapy (DMT) in the past 6 months
- Antipsychotics, anticholinergics, anticonvulsants, and other antidepressants, benzodiazepines, or other psychotropic medications and blood thinners, except for aspirin at a prophylactic dose or less.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Computerized Olfactory Training (COT) Device with olfactory stimulants
COT device with olfactory stimulants consists of daily 40 cycles of intervention with a combination of olfactory stimulation and training tasks, lasting ~45 minutes, delivered once daily over 6 months period by the participant or their partner/caregiver.
|
The COT with proprietary odorant molecules is designed to stimulate olfactory neural activity over long periods of time combined with orbitofrontal cortex (OFC) dependent olfactory tasks.
Andre navne:
|
Sham-komparator: Sham/COT Device
This is COT device that uses compressed room air scented with phenylethylamine (rose scent) instead of olfactory stimulants and has shape pattern matching tasks instead of cognitive tasks, in order to blind users to their treatment assignment.
Similar to the COT, sham COT will be used daily for 45 minutes.
|
Sham COT uses artificially scented compressed room air instead of olfactory stimulants and has control cognitive olfactory tasks.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Logical Memory II subscale (Delayed Paragraph Recall)
Tidsramme: Baseline
|
Measures patient's ability to recall information after a 20 to 30 minutes delay for story b from the Wechsler Memory Scale-IV (0-25).
Higher scores indicate better performance.
This is use for evaluation of forgetting or memory decay.
|
Baseline
|
Logical Memory II subscale (Delayed Paragraph Recall)
Tidsramme: 6 months
|
Measures patient's ability to recall information after a 20 to 30 minutes delay for story b from the Wechsler Memory Scale-IV (0-25).
Higher scores indicate better performance.
This is use for evaluation of forgetting or memory decay.
|
6 months
|
Logical Memory II subscale (Delayed Paragraph Recall)
Tidsramme: 9 months
|
Measures patient's ability to recall information after a 20 to 30 minutes delay for story b from the Wechsler Memory Scale-IV (0-25).
Higher scores indicate better performance.
This is use for evaluation of forgetting or memory decay.
|
9 months
|
ADCS-PACC composite score
Tidsramme: Baseline
|
Combines tests that assess episodic memory, timed executive function and global cognition.
Alzheimer's Disease Cooperative Study (ADCS) PACC (ADAS-PACC) is a composite score of: The Total Recall score from the Free and Cued Selective Reminding Test (FCSRT) (range from 0-48 points), The Delayed Recall score on the Logical Memory IIa subtest from the Wechsler Memory Scale (range from 0-25 points), the Digit Symbol Substitution Test score from the Wechsler Adult Intelligence Scale-Revised (range from 0-93 points), and the MMSE score (range from 0-30 points).
Each of the component change scores is divided by the baseline sample standard deviation of that component, to form standardized z scores.
These z scores are summed to form the composite.
Z Scores could range from -5 to +5 with higher scores indicating less deficit and lower scores indicating greater deficit.
|
Baseline
|
ADCS-PACC composite score
Tidsramme: 6 months
|
Combines tests that assess episodic memory, timed executive function and global cognition.
Alzheimer's Disease Cooperative Study (ADCS) PACC (ADAS-PACC) is a composite score of: The Total Recall score from the Free and Cued Selective Reminding Test (FCSRT) (range from 0-48 points), The Delayed Recall score on the Logical Memory IIa subtest from the Wechsler Memory Scale (range from 0-25 points), the Digit Symbol Substitution Test score from the Wechsler Adult Intelligence Scale-Revised (range from 0-93 points), and the MMSE score (range from 0-30 points).
Each of the component change scores is divided by the baseline sample standard deviation of that component, to form standardized z scores.
These z scores are summed to form the composite.
Z Scores could range from -5 to +5 with higher scores indicating less deficit and lower scores indicating greater deficit.
|
6 months
|
ADCS-PACC composite score
Tidsramme: 9 months
|
Combines tests that assess episodic memory, timed executive function and global cognition.
Alzheimer's Disease Cooperative Study (ADCS) PACC (ADAS-PACC) is a composite score of: The Total Recall score from the Free and Cued Selective Reminding Test (FCSRT) (range from 0-48 points), The Delayed Recall score on the Logical Memory IIa subtest from the Wechsler Memory Scale (range from 0-25 points), the Digit Symbol Substitution Test score from the Wechsler Adult Intelligence Scale-Revised (range from 0-93 points), and the MMSE score (range from 0-30 points).
Each of the component change scores is divided by the baseline sample standard deviation of that component, to form standardized z scores.
These z scores are summed to form the composite.
Z Scores could range from -5 to +5 with higher scores indicating less deficit and lower scores indicating greater deficit.
|
9 months
|
Olfactory Psychophysical Tasks scores
Tidsramme: Baseline
|
Using Sniffin' sticks, defines patient's olfactory threshold (T), discrimination (D) and identification (I).
Scores: Male and Female threshold score (1-16); Male and Female discrimination score (4-16); Identification score (male: 3-16; female: 4-16); Threshold Discrimination Identification (TDI) composite score (male: 9-44; female: 11-43).
Higher score indicates better olfactory performance.
|
Baseline
|
Olfactory Psychophysical Tasks scores
Tidsramme: 6 months
|
Using Sniffin' sticks, defines patient's olfactory threshold (T), discrimination (D) and identification (I).
Scores: Male and Female threshold score (1-16); Male and Female discrimination score (4-16); Identification score (male: 3-16; female: 4-16); TDI composite score (male: 9-44; female: 11-43).
Higher score indicates better olfactory performance.
|
6 months
|
Olfactory Psychophysical Tasks scores
Tidsramme: 9 months
|
Using Sniffin' sticks, defines patient's olfactory threshold (T), discrimination (D) and identification (I).
Scores: Male and Female threshold score (1-16); Male and Female discrimination score (4-16); Identification score (male: 3-16; female: 4-16); TDI composite score (male: 9-44; female: 11-43).
Higher score indicates better olfactory performance.
|
9 months
|
Changes in cortical thickness and grey matter volumes
Tidsramme: Baseline and 9 months
|
Defines as MRI imaging changes of the hippocampus and entorhinal cortex
|
Baseline and 9 months
|
Changes in subfield segmentations of the hippocampus and entorhinal cortex
Tidsramme: Baseline and 9 months
|
Using the Automatic Segmentation of Hippocampal subfields looking for changes in the hippocampus and entorhinal cortex
|
Baseline and 9 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Changes in the scores of Neuropsychological Test Battery (NTB)
Tidsramme: Baseline, 6 months and 9 months
|
Neuropsychological Test Battery (NTB) is a combination of widely used clinical neuropsychological tests measuring memory and executive function.
he total Neuropsychological Test Battery (NTB) executive function is a composite score obtained from averaging the following three z-scores from the NTB: Wechsler Memory Scale Digit Span, Controlled Word Association Test (COWAT), and Category Fluency Test (CFT).
The range in z scores is from -3 to 3; higher scores indicating less executive function deficit.
|
Baseline, 6 months and 9 months
|
Changes in the scores of Mini Mental State Examination (MMSE)
Tidsramme: Baseline, 6 months and 9 months
|
Mini Mental State Examination (MMSE) measures cognitive function and includes tests of orientation, attention, memory, language and visual-spatial skills.
MMSE range 0 - 30; higher scores indicating less deficit.
|
Baseline, 6 months and 9 months
|
Changes in the scores of CDR scale (CDR)
Tidsramme: Baseline, 6 months and 9 months
|
Clinical Dementia Rating Scale (CDR) is a 5- point scale used to characterize six domains of cognitive and functional performance (Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care) applicable to Alzheimer's disease and related dementias. CDR Score is the sum of boxes scores range from 0 - 18; higher scores indicating worse deficit. |
Baseline, 6 months and 9 months
|
Changes in the scores of Global Deterioration Scale(GDS)
Tidsramme: Baseline, 6 months and 9 months
|
GDS provides an overview of the stages of cognitive function for those suffering from primary degenerative dementia such as Alzheimer's disease.
Geriatric Depression Scale (GDS) scores range from 0 - 30; higher scores indicating worse depression.
|
Baseline, 6 months and 9 months
|
Changes in the scores of Activities of Daily Living (ADCS-ADL)
Tidsramme: Baseline, 6 months and 9 months
|
ADCS-ADL is used for assessment of patient's ability to perform activities of daily living.
ADCS-ADL is a 23-item activities of daily with score range from 0 - 78; lower scores indicating greater impairment.
|
Baseline, 6 months and 9 months
|
Changes in the scores of Quality of Life scale (QOL)
Tidsramme: Baseline, 6 months and 9 months
|
QOL measures satisfaction, perceptions of control, involvement, commitment and work-life balance, in terms of one's personal perception.
QOL-AD score ranges from 13 - 52; higher scores indicating less deficit.
|
Baseline, 6 months and 9 months
|
Changes in odor discrimination scores
Tidsramme: Baseline, 9 months
|
Odor discrimination score defines patient's ability to detect differences between odors.
|
Baseline, 9 months
|
Changes in the grey matter volumes of other structures of the primary olfactory cortex
Tidsramme: Baseline, 9 months
|
Primary olfactory region images will use MPRAGE MRI sequence for grey matter volume
|
Baseline, 9 months
|
Changes in the cortical thickness of other structures of the primary olfactory cortex
Tidsramme: Baseline, 9 months
|
Primary olfactory region images will use MPRAGE MRI sequence for cortical thickness
|
Baseline, 9 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Evaristus Nwulia, MD, Evon Medics LLC
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- COTAG061981
- 2R44AG061981-03 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mild kognitiv svækkelse
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RekrutteringSøvnforstyrrelser | AMCI - Amnestic Mild Cognitive ImpairmentForenede Stater
-
Dart NeuroScience, LLCAfsluttetAge-Associated Memory Impairment (AAMI)Forenede Stater
-
Charité Neurocure AG FlöelUkendtAfasi | Anomi (ord-finding impairment)Tyskland
-
St. Boniface HospitalPizzey Ingredients; Canadian Agricultural PartnershipAktiv, ikke rekrutterendeHukommelse; Forstyrrelse, MildCanada
-
XtremeVRI AGAristotle University Of Thessaloniki; Klinik Hirslanden, Zurich; Greek Alzheimer...AfsluttetSund og rask | Mild kognitiv svækkelse, så angivet | Mild demens
-
Aristotle University Of ThessalonikiGreek Alzheimer's Association and Related DisordersAfsluttetSund og rask | Mild kognitiv svækkelse, så angivet | Mild demens
-
Mitsubishi Tanabe Pharma America Inc.AfsluttetMild og moderat nedsat leverfunktionForenede Stater
-
Maastricht University Medical CenterRekrutteringMild kognitiv svækkelse | Mild demens | Amnestisk mild kognitiv lidelseHolland
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RekrutteringMild kognitiv svækkelse (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute... og andre samarbejdspartnereAfsluttetMild kognitiv svækkelse (MCI)Forenede Stater
Kliniske forsøg med COT
-
Hacettepe UniversityAfsluttetTræthed | Ydeevne | Barnekræft | Funktionel uafhængighedKalkun
-
Indonesia UniversityAfsluttetEfter abdominal kirurgiIndonesien
-
University of California, San DiegoNational Cancer Institute (NCI); University of Michigan; Arizona State University og andre samarbejdspartnereRekrutteringStillesiddende adfærd | Inaktivitet, fysiskForenede Stater
-
Jens BräunlichRekrutteringHyperkapnisk respirationssvigt | Hypoxæmisk respirationssvigt | Akut viral bronkitisTyskland
-
Hacettepe UniversityUskudar UniversityAfsluttet
-
Toronto Rehabilitation InstituteThe Physicians' Services Incorporated Foundation; Christopher Reeve Paralysis...Afsluttet
-
Nanfang Hospital, Southern Medical UniversityRekrutteringPapillær skjoldbruskkirtelkræftKina
-
University of FloridaFisher and Paykel HealthcareRekruttering
-
Amsterdam UMC, location VUmcAktiv, ikke rekrutterendeCOVID-19 | Hypoxæmisk respirationssvigtHolland
-
Ain Shams UniversityRekrutteringØvre gastrointestinale blødningerEgypten